Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiogenesis
New data from P. Albers et al illuminate research in angiogenesis
April 22nd, 2008
According to a study from Kassel, Germany, "Treatment of localised renal cell carcinoma (RCC) is well established, and surgical resection is curative for most patients. However, for patients with either metastatic disease or whose local disease subsequently metastasises, treatment options have until recently been limited to cytokine therapy or chemotherapy, both of which are ineffective in the majority." "As a result, prognosis has been poor for patients with metastatic RCC (mRCC). A better understanding of the pathogenesis of RCC has led to the development and application of therapies targeted at key molecules involved in angiogenesis, which is an integral part of...
Source: Cancer Weekly (2008-04-22)
|
